Notice ID: cb1140c96dc941cbb2c5f0769d83d9d1Special Notice
FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Archived on September 30, 2025. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 11:59 PM UTC−05:00
- Posted
- February 26, 2025
- Notice type
- Special Notice
- NAICS
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA Office of Acquisitions and Grants Services
- Place of performance
- Silver Spring, 20993
- PSC
- AJ11: GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
- Last updated
- Dec 5, 2025
Identifiers
- Solicitation number
- FDABAA-25-00123
- Notice ID
- cb1140c96dc941cbb2c5f0769d83d9d1
Description
Amendment 05 - The BAA Notice has been updated to version 6 with various changes throughout. Amendment 04 - The BAA Notice has been updated to version 5 with various changes throughout. Table 1 and attachment 5 have also been updated and included seperately. The response date has been changed to March 04th at 1159 PM EST. Amendment 03 - The BAA Notice has been updated to version 4 with various changes throughout, Table 1 and attachments 4 and 5 have also been updated and included seperately. Amendment 02 - The BAA Notice has been updated to version 3 with various changes throughout. Amendment 01 - The BAA Notice has been updated to version 2 with various changes throughout, and table 1 has been updated and included seperately. In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation. Join us to learn more about the FY 2025 BAA, and how to apply. Save the date for the 2024 FDA Broad Agency Announcement (BAA) Day! November 14th, 2024. BAA Day for FY25 2024 will be hosted on November 14th, 2024, as a virtual only event and will provide an opportunity to learn more about the application process and FDAs priorities for regulatory research. https://www.fda.gov/science-research/advancing-regulatory-science/2024-fda-broad-agency-announcement-day-11142024
Award Overview
Contacts
Contracting Officer
Primary Contact
Documents
No documents available.
Lifecycle
Solicitation:
FDABAA-25-00123- 9×Special NoticeCurrentOct 3, 2024
FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Similar Opportunities
- FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Department of Health and Human Services · Posted 10/30/2026
- FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Department of Health and Human Services · Posted 10/08/2026
- Quantitative Analysis of Longitudinal MR Images
Department of Health and Human Services · Posted 10/23/2026
- Pre-Clinical Models of Infectious Diseases
Department of Health and Human Services · Posted 10/19/2026
- Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
Department of Health and Human Services · Posted 10/01/2026
Additional Details
Solicitation Number
FDABAA-25-00123
Archive Date
Sep 30, 2025